Rigel Pharmaceuticals, Inc. (RIGL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)

RIGL 35.20

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (27)	1/17/2002 9:55:48 AM
From: tuck	Read Replies (1) of 566

>>SOUTH SAN FRANCISCO, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL - news) today announced it has entered into an agreement with Robertson Stephens, as placement agent, providing for the placement of newly-issued shares of Rigel's common stock. Robertson Stephens has received commitments from a select group of existing and new investors to purchase 7.0 million shares of Rigel's common stock at a price of $4.50 per share. The shares of common stock are being offered through a prospectus supplement pursuant to the company's effective shelf registration statement. The sale of all of the 7.0 million shares is expected to raise net proceeds of approximately $29.4 million, after payment by Rigel of placement agent fees and offering expenses. A registration statement relating to these securities was filed with and has been declared effective by the U.S. Securities and Exchange Commission. Copies of the prospectus supplement and accompanying prospectus related to the offering may be obtained from Robertson Stephens, 555 California Street, Suite 2600, San Francisco, California 94104.<< snip Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next